Body Mass Index and the Risk of Atrial Fibrillation: A Mendelian Randomization Study

Nutrients. 2022 Apr 29;14(9):1878. doi: 10.3390/nu14091878.

Abstract

Although observational studies have shown positive associations between body mass index (BMI) and the risk of atrial fibrillation (AF), the causal relationship is still uncertain owing to the susceptibility to confounding and reverse causation. This study aimed to examine the potential causality of BMI on AF by conducting a two-sample Mendelian randomization (TSMR) study.

Methods: The independent genetic variants associated with BMI (n = 303) at the genome-wide significant level were derived as instrumental variables (IV) from the Genetic Investigation of Anthropometric Traits (GIANT) consortium consisting of 681,275 individuals of European ancestry. We then derived the outcome data from a GWAS meta-analysis comprised of 60,620 cases and 970,216 controls of European ancestry. The TSMR analyses were performed in five methods, namely inverse variance weighted (IVW) method, MR-Egger regression, the weighted median estimator (WME), the generalized summary data-based Mendelian randomization (GSMR), and the robust adjusted profile score (RAPS), to investigate whether BMI was causally associated with the risk of AF.

Results: We found a genetically determined 1-standard deviation (SD) increment of BMI causally increased a 42.5% risk of AF (OR = 1.425; 95% CI, 1.346 to 1.509) based on the IVW method, which was consistent with the results of MR-Egger regression, WME, GSMR, as well as RAPS. The Mendelian randomization assumptions did not seem to be violated.

Conclusion: This study provides evidence that higher BMI causally increased the risk of AF, suggesting control of BMI and obesity for prevention of AF.

Keywords: BMI; Mendelian randomization; atrial fibrillation; causal inference.

Publication types

  • Meta-Analysis

MeSH terms

  • Atrial Fibrillation* / epidemiology
  • Atrial Fibrillation* / genetics
  • Body Mass Index
  • Genome-Wide Association Study
  • Humans
  • Mendelian Randomization Analysis* / methods
  • Polymorphism, Single Nucleotide

Grants and funding

This research was funded by the National Natural Science Foundation of China (81673259), Natural Science Foundation of Jiangsu Province, China (BK20161435) and Jiangsu Commission of Health (H2019079).